Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

Abdominal cancer refers to any malignant tumor in the abdomen, including stomach, liver, pancreatic, or colon cancer. Symptoms vary but may include unexplained weight loss, abdominal pain, and changes in bowel habits. Early detection is crucial for successful treatment, which may involve surgery, chemotherapy, or radiation.

Liposuction is particularly effective at removing fat in the legs, abdomen, back, arms, face, and neck. It provides more dramatic results than other noninvasive fat reduction procedures, however, it has a longer recovery period (up to six weeks) and typically costs more than its nonsurgical counterparts. Bariatric Surgery Turkey Price For more details in our article, What is the best surgery to remove belly fat where you will find all the information about What is the best surgery to remove belly fat please... +More

Bariatric surgery refers to procedures that help with weight loss by altering the digestive system. This includes operations like gastric bypass, sleeve gastrectomy, and adjustable gastric banding. Bariatric surgery is often recommended for individuals with a BMI over 40 or a BMI over 35 with obesity-related health conditions.

Wegovy is available through the NHS for patients meeting specific criteria. To qualify, individuals generally need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as diabetes or hypertension. Wegovy is a relatively new option and is prescribed under careful medical supervision.